1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BICARA THERAPEUTICS INC.
Bicara Therapeutics Inc. XNAS: BCAX
14.64 0.07 (0.48%)
654.1K
XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Bicara Therapeutics Inc. is on 12 Nov 2025 for the purpose of Bicara Therapeutics Inc Third Quarter Earnings Results for 2025 See details


Insider Trading disclosures for Bicara Therapeutics Inc.

The latest disclosure was made by Claire Mazumdar in Bicara Therapeutics Inc. where a trade of 24,103 Common Stock done at an average price of $18.8 was reported to US exchanges on Oct. 16, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Claire Mazumdar Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 18.83 per share. 16 Oct 2025 24,103 309,892 - 18.8 453,761 Common Stock
Claire Mazumdar Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Oct 2025 24,103 277,270 - - Stock Option (Right to Buy)
Claire Mazumdar Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 16 Oct 2025 24,103 333,995 - 3.8 91,346 Common Stock
Ryan Cohlhepp Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Oct 2025 8,000 157,334 - - Stock Option (Right to Buy)
Ryan Cohlhepp Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 15 Oct 2025 8,000 210,641 - 3.8 30,318 Common Stock
Ryan Cohlhepp Director, President and COO Sale of securities on an exchange or to another person at price $ 18.16 per share. 15 Oct 2025 8,000 202,641 - 18.2 145,243 Common Stock
Ryan Cohlhepp Director, President and COO Sale of securities on an exchange or to another person at price $ 18.16 per share. 15 Oct 2025 4,500 198,141 - 18.2 81,699 Common Stock
Claire Mazumdar Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 18.92 per share. 13 Oct 2025 11,445 309,892 - 18.9 216,545 Common Stock
Claire Mazumdar Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 13 Oct 2025 13,289 323,181 - 3.8 50,363 Common Stock
Claire Mazumdar Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 18.84 per share. 13 Oct 2025 13,289 309,892 - 18.8 250,391 Common Stock
Claire Mazumdar Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Oct 2025 11,445 314,662 - - Stock Option (Right to Buy)
Claire Mazumdar Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 13 Oct 2025 13,289 301,373 - - Stock Option (Right to Buy)
Claire Mazumdar Director, Chief Executive Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 13 Oct 2025 11,445 321,337 - 3.8 43,374 Common Stock
Ivan Hyep Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.23 per share. 09 Oct 2025 6,415 145,355 - 18.2 116,931 Common Stock
Ivan Hyep Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 09 Oct 2025 6,415 151,770 - 3.8 24,312 Common Stock
Ivan Hyep Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Oct 2025 6,415 116,584 - - Stock Option (Right to Buy)
David Raben Chief Medical Officer Sale of securities on an exchange or to another person at price $ 18.45 per share. 09 Oct 2025 22,000 35,497 - 18.5 405,900 Common Stock
David Raben Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 09 Oct 2025 22,000 57,497 - 3.8 83,376 Common Stock
David Raben Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 09 Oct 2025 22,000 128,870 - - Stock Option (Right to Buy)
Ivan Hyep Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Oct 2025 18,244 128,626 - - Stock Option (Right to Buy)
Ryan Cohlhepp Director, President and COO Sale of securities on an exchange or to another person at price $ 18.06 per share. 06 Oct 2025 2,900 202,641 - 18.1 52,371 Common Stock
Ryan Cohlhepp Director, President and COO Sale of securities on an exchange or to another person at price $ 18.06 per share. 06 Oct 2025 8,000 205,541 - 18.1 144,473 Common Stock
Ryan Cohlhepp Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 06 Oct 2025 8,000 213,541 - 3.8 30,318 Common Stock
Ryan Cohlhepp Director, President and COO Sale of securities on an exchange or to another person at price $ 18.06 per share. 06 Oct 2025 15,600 205,541 - 18.1 281,666 Common Stock
Ryan Cohlhepp Director, President and COO Sale of securities on an exchange or to another person at price $ 18.06 per share. 06 Oct 2025 24,000 221,141 - 18.1 433,332 Common Stock
Ivan Hyep Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.17 per share. 06 Oct 2025 6,514 145,355 - 18.2 118,356 Common Stock
Ivan Hyep Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 06 Oct 2025 6,514 151,869 - 3.8 24,687 Common Stock
Ivan Hyep Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Oct 2025 5,627 122,999 - - Stock Option (Right to Buy)
Ivan Hyep Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Oct 2025 6,514 146,870 - - Stock Option (Right to Buy)
Ivan Hyep Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.21 per share. 06 Oct 2025 5,627 145,355 - 18.2 102,456 Common Stock
Ivan Hyep Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 06 Oct 2025 5,627 150,982 - 3.8 21,325 Common Stock
Ivan Hyep Chief Financial Officer Sale of securities on an exchange or to another person at price $ 18.22 per share. 06 Oct 2025 18,244 145,355 - 18.2 332,386 Common Stock
Ivan Hyep Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 06 Oct 2025 18,244 163,599 - 3.8 69,141 Common Stock
Ryan Cohlhepp Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Oct 2025 24,000 173,334 - - Stock Option (Right to Buy)
Ryan Cohlhepp Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 06 Oct 2025 8,000 165,334 - - Stock Option (Right to Buy)
Ryan Cohlhepp Director, President and COO Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.79 per share. 06 Oct 2025 24,000 245,141 - 3.8 90,955 Common Stock
Lara Meisner Chief Legal Officer Sale of securities on an exchange or to another person at price $ 14.75 per share. 29 Sep 2025 33,807 0 - 14.7 498,653 Common Stock
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Sep 2025 33,807 101,423 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.24 per share. 29 Sep 2025 33,807 33,807 - 9.2 312,495 Common Stock
Lara Meisner Chief Legal Officer Sale of securities on an exchange or to another person at price $ 11.49 per share. 15 Sep 2025 15,829 0 - 11.5 181,875 Common Stock
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2025 6,085 54,769 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Sep 2025 9,744 87,699 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. 15 Sep 2025 15,829 15,829 - 5.4 86,268 Common Stock
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. 16 Jun 2025 15,829 15,829 - 5.4 86,268 Common Stock
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jun 2025 6,085 60,854 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jun 2025 9,744 97,443 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Sale of securities on an exchange or to another person at price $ 10.43 per share. 16 Jun 2025 15,829 0 - 10.4 165,096 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2025 23,746 23,746 - - Stock Option (Right to Buy)
Michael F. Powell Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2025 23,746 23,746 - - Stock Option (Right to Buy)
Christopher Bowden Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2025 23,746 23,746 - - Stock Option (Right to Buy)
Scott Robertson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2025 23,746 23,746 - - Stock Option (Right to Buy)
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jun 2025 23,746 23,746 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 30,246 67,119 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Mar 2025 48,720 107,187 - - Stock Option (Right to Buy)
Lara Meisner Chief Legal Officer Sale of securities on an exchange or to another person at price $ 13.24 per share. 14 Mar 2025 30,620 0 - 13.2 405,513 Common Stock
Lara Meisner Chief Legal Officer Sale of securities on an exchange or to another person at price $ 12.69 per share. 14 Mar 2025 48,526 30,620 - 12.7 615,698 Common Stock
Lara Meisner Chief Legal Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. 14 Mar 2025 79,146 79,145 - 5.5 431,346 Common Stock
Jake Simson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 1,080,775 1,080,775 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 4,327,365 4,443,122 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 3,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 9,990,144 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 40,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 432,736 432,736 - 0 Common Stock
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 324,552 324,552 - 0 Common Stock
Scott Robertson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2024 23,746 23,746 - - Stock Option (Right to Buy)
Kiran Mazumdar-Shaw Director, Ten Percent Owner 12 Sep 2024 4,000,000 0 - - Series Seed Redeemable Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures